Michael A. Robinson- Money Morning - Only the News You Can Profit From.
Michael'S LATEST HEADLINES
- Investing 0 Tuesday, May 26, 2020Five Reasons Why This Biotech Stock Could Double Your Money in Just Two Years
In our twice-weekly chats, I often suggest investments that are part of large tech sectors.
For instance, the life sciences field defines huge. Just the prescription drug segment alone will be worth $1.2 trillion by 2024, according to data from Statista.
So, you might be wondering why I am focused on a medical area that will be worth just 0.1% of that figure over roughly the same time frame.
It's a fair question. The answer is pretty basic. A high-octane leader
focused on specialty drugs can make a killing.
And the one I'm going to reveal to you today defines profit machine. It's on pace to double per-share earnings in as little as a year.With that in mind, let me show you five reasons why this wealth-building biotech firm should at the very least be on your radar screen....
- COVID-19 Stock Market Crash Monday, May 25, 20205G's Unstoppable Momentum Could Bring a Potential Upgrade to Every Future Smartphone
- COVID-19 Stock Market Crash Saturday, May 23, 2020This Money-Doubling Classic Could Lead an Outer Space "Gold Rush"
- COVID-19 Stock Market Crash Saturday, May 16, 2020A New Innovative 5G Network Could Launch by Year's End, Driving This Company Up 100% or More
- COVID-19 Stock Market Crash Friday, May 15, 2020Wall Street Keeps Ignoring This AI Leader – and the Stock Is a Bargain
- Bonds Friday, May 8, 2020A High-Tech Way to Cash In on Investors' Endless Search for Yield
- COVID-19 Stock Market Crash Friday, May 1, 2020Microsoft's "Right-Hand Man" Could Double Your Money Before the Economy Recovers
- Thursday, April 30, 2020Three Income Champions to Lead the
- Apple Wednesday, April 29, 2020The Perfect Time to Buy Apple Stock Is Right Around the Corner
- COVID-19 Stock Market CrashThree "COVID-Killer" Technologies – and Three Ways Investors Can Ride Along for Profit